tis (OA) is driven by a low-grade inflammation in the synovium. Pro-inflammatory cytokines released locally during OA, such as S100A8/A9 which are expressed for prolonged periods when compared to IL-1β, IL-6, and TNF-α, may recruit monocytes from the bone marrow (BM) to the joint. In mice, two functionally distinct monocyte populations are described: (i) pro-inflammatory Ly6C high monocytes; and (ii) patrolling Ly6C low monocytes. Objectives: The objective of our study is to investigate the role of S100A8/A9 in the recruitment of the different monocyte populations during early collagenaseinduced OA (CiOA). Methods: S100A8 was intra-articularly injected into the knee joint of naïve wild type C57BL/6 (WT) mice to investigate their direct role in recruitment of monocytes. CiOA was induced by unilateral intra-articular collagenase injection in WT, and S100A9KO mice to investigate the role of S100A8/A9 in more detail. At CiOA day 7, WT and S100A9KO mice were sacrificed together with age-matched saline-injected control mice (n=6/group), and expression of several monocyte cell markers, chemokines, and adhesion molecules were measured in the synovium and BM, in which the cells were also analyzed by FACS. Monocytes were identified as (B220/CD90/CD49b/NK1.1/Ly6G) low CD11b high (F4/80/MHCII/CD11c) low , which were further divided into subsets based on their Ly6C expression. Results: Injection of S100A8 into the knee joints of naïve mice led to a significantly elevated expression of monocyte-related markers (Ly6C, CCR2, and CX3CR1) and monocyte attracting chemokines (MCP-1, CX3CL1, MIP1α, and KC) within the synovium after 1 and 3 days, suggesting that S100A8/A9 is directly involved in the attraction of monocytes. At CiOA day 7 in WT mice, numbers of Ly6C high , but not Ly6C low monocytes, were strongly increased (7.6-fold) in the synovium as compared to saline-injected control joints. In contrast, S100A9KO mice showed a significant increase in Ly6C low monocytes (2-fold), whereas the number of Ly6C high monocytes remained unaffected. Concurrently, a strong upregulation of several chemokines (MCP1, CX3CL1, KC, and MIP1α) was observed locally in the synovium, of which only the Ly6C low mobilization marker CX3CL1 was significantly higher in S100A9KO mice, corresponding with the increased Ly6C low monocytes in the synovium of S100A9KO mice. This could however not explain the local increased number of Ly6C high monocytes at CiOA day 7 in WT mice, and therefore we next investigated the main source of the monocytes, which is the BM. We observed a decrease of 14% of myeloid cells (consisting partly of Ly6C high monocytes) in the BM of WT mice at CiOA day 7, whereas there were no changes in the BM of S100A9KO mice, suggesting that S100A8/A9 affects the release of myeloid populations from the BM. In line with that, expression of adhesion molecules (LFA-1, VCAM, VE-cadherin, PECAM1, and L-selectin) was lower at CiOA day 7 in the BM of S100A9KO mice when compared to WT mice. Conclusions: Local induction of OA leads to S100A8/A9 production, and subsequently to the mobilization of Ly6C high monocytes into the joint, driving OA pathology.
tis (OA) is driven by a low-grade inflammation in the synovium. Pro-inflammatory cytokines released locally during OA, such as S100A8/A9 which are expressed for prolonged periods when compared to IL-1β, IL-6, and TNF-α, may recruit monocytes from the bone marrow (BM) to the joint. In mice, two functionally distinct monocyte populations are described: (i) pro-inflammatory Ly6C high monocytes; and (ii) patrolling Ly6C low monocytes. Objectives: The objective of our study is to investigate the role of S100A8/A9 in the recruitment of the different monocyte populations during early collagenaseinduced OA (CiOA). Methods: S100A8 was intra-articularly injected into the knee joint of naïve wild type C57BL/6 (WT) mice to investigate their direct role in recruitment of monocytes. CiOA was induced by unilateral intra-articular collagenase injection in WT, and S100A9KO mice to investigate the role of S100A8/A9 in more detail. At CiOA day 7, WT and S100A9KO mice were sacrificed together with age-matched saline-injected control mice (n=6/group), and expression of several monocyte cell markers, chemokines, and adhesion molecules were measured in the synovium and BM, in which the cells were also analyzed by FACS. Monocytes were identified as (B220/CD90/CD49b/NK1.1/Ly6G) low CD11b high (F4/80/MHCII/CD11c) low , which were further divided into subsets based on their Ly6C expression. Results: Injection of S100A8 into the knee joints of naïve mice led to a significantly elevated expression of monocyte-related markers (Ly6C, CCR2, and CX3CR1) and monocyte attracting chemokines (MCP-1, CX3CL1, MIP1α, and KC) within the synovium after 1 and 3 days, suggesting that S100A8/A9 is directly involved in the attraction of monocytes. At CiOA day 7 in WT mice, numbers of Ly6C high , but not Ly6C low monocytes, were strongly increased (7.6-fold) in the synovium as compared to saline-injected control joints. In contrast, S100A9KO mice showed a significant increase in Ly6C low monocytes (2-fold), whereas the number of Ly6C high monocytes remained unaffected. Concurrently, a strong upregulation of several chemokines (MCP1, CX3CL1, KC, and MIP1α) was observed locally in the synovium, of which only the Ly6C low mobilization marker CX3CL1 was significantly higher in S100A9KO mice, corresponding with the increased Ly6C low monocytes in the synovium of S100A9KO mice. This could however not explain the local increased number of Ly6C high monocytes at CiOA day 7 in WT mice, and therefore we next investigated the main source of the monocytes, which is the BM. We observed a decrease of 14% of myeloid cells (consisting partly of Ly6C high monocytes) in the BM of WT mice at CiOA day 7, whereas there were no changes in the BM of S100A9KO mice, suggesting that S100A8/A9 affects the release of myeloid populations from the BM. In line with that, expression of adhesion molecules (LFA-1, VCAM, VE-cadherin, PECAM1, and L-selectin) was lower at CiOA day 7 in the BM of S100A9KO mice when compared to WT mice. Conclusions: Local induction of OA leads to S100A8/A9 production, and subsequently to the mobilization of Ly6C high monocytes into the joint, driving OA pathology. + DC are a rare population of DC that were first discovered in 2010 in human peripheral blood. Due to their rarity very little is known about the function of these cells in other tissue in or indeed disease. These newly described DC subset have thus never been described in Inflammatory Arthritis (IA) or any of the rheumatic diseases. Objectives: To identify CD141 DC in IA synovium and functionally assess if these cells play a pathogenic role in IA. Methods: CD141 + DC were magnetically purified from synovial fluid mononuclear cells (SFMC) and peripheral blood mononuclear cells (PBMC) stimulated and stained with a panel of fluorochrome conjugated antibodies for multicolour flow cytometry. CD141 + DC isolated and purified from IA synovial fluid were subsequently cocultured with allogenic CD3 + T cells for 6d after which intracellular cytokine production was assessed by flow cytometry. Supernatants from this DC-T cell cocultures were used to treat synovial fibroblasts & the expression of adhesion molecules, cytokines & MMPs was measured. Finally using sorted populations of CD141 + DC from SFMC and PBMC, RNA sequencing was performed and differentially expressed genes and interaction network analysis were identified using the DeSeq2 R package, Background: The present study was undertaken to investigate novel anti-hnRNPs autoantibodies in rheumatic diseases. Objectives: Novel mutated hnRNP A3 was cloned out of RA synovial tissue linking it directly to Warburg effect and lactate production in RA. Increased lactate production in RA synovia and tumors is klinked to alternative splicing process from PKM1 to PKM2 hnRNPs dependent. Methods: After immunobloting and 2D-gel-eletrophoresis of a semipurified hnRNP fraction two protein spots were sequenced and identified to be highly similar to hnRNPA3. The hnRNP A3 variants were cloned from RA synovial tissue, which identified the isoforms found on protein level. 3700 RA sera were screened for the presence of mutated anti-hnRNP A3 autoantibodies using recombinant proteins and peptides thereof. Binding of RNA to hnRNP A3 (MA3) and mutated citrullinated A3 peptides (MCA3) the epitope recognition was investigated. Expression of hnRNP A3 in synovial tissue was analysed by Results: Autoantibodies to MA3 protein were detected in 13% of RA (n=215) patients, in 9% SLE (n=154), in 27% of MCTD patients (n=44/10) and in less than 5% of 129 patients with other rheumatic disorders but not at all in healthy controls on immunoblot. When using renaturated MA3 on ELISA 22% of RA patients were detected and 87% of these patients had erosive arthritis. Same modification as in cancer cells were identified in synovial tissue and verified by MS and DNA sequencing. Using 2-3 citrullinated MCA3 peptides up to 81% of patients (n=150) with established and 67% (n=2926) of patients with an early RA with a specificity of 97% were detected. In early RA 27% and 25% in established RA of CCP2 negative and 93% of CCP2 positive patients were identified. By combining with the already established CCP2 and the new MCA3, 72% of early patients are positive. MCA3 autoantibodies predominantly occur (p<0.001) in an erosive, severe course of disease and approximately 60% of these patients receive a TNF alpha blocker within a year. MRL Lpr/lpr sera were hnRNP-A3 reactive and the antibody generation is Toll 7 and 9 dependent. Anti-hnRNP-A3-antibodies are directed to conformational RNA binding epitopes. Expression of hnRNP-A3 revealed the antigen to be overexpressed in RA synovial tissue. Conclusions: Mutated hnRNP-A3 is as a novel Toll7/9 dependent autoantigen in systemic rheumatic diseases. These mutated proteins are major components of RNA and DNA containing alternative splicing complexes leading to the Warburg effect and and autoantibodies predominantly occurre in an erosive, and severe courses of RA.
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